Advertisements


We are Sorry, This Page doesn't Exist


: Pharma industry warns against interfering with COVID vaccine shot intervals

Governments and national health authorities should “stick to the dosing that has been assessed in clinical trials,” said U.S. and European pharmaceutical industry organizations......»»

Category: topSource: marketwatchJan 14th, 2021

FDA Warns Against Tinkering With Pfizer, Moderna Vaccine Regimens After White House Advisor"s Comments

The United States Food and Drug Administration has warned against changing the dosing regimen, interval, or mixing of COVID-19 vaccines in a statement issued Monday. read more.....»»

Category: blogSource: benzingaJan 5th, 2021

Novavax starts Phase 3 COVID vaccine trial with plans to enroll 30,000 volunteers in U.S. and Mexico

Novavax Inc. said Monday it is starting a late-stage trial of its COVID-19 vaccine candidate with plans to enroll up to 30,000 volunteers at about 115 sites in .....»»

Category: topSource: marketwatchDec 28th, 2020

FDA clears Gilead"s Covid-fighting drug remdesivir

A once-failed Gilead Sciences Inc. drug, turned a superstar in the Covid-19 crisis, was given emergency use authorization Friday by federal regulators. Remdesivir, which scored positive results in late-stage clinical trials by Foster City-based Gilead (.....»»

Category: topSource: bizjournalsMay 1st, 2020

AstraZeneca teams up with Oxford University to develop coronavirus vaccine — first results from human trials expected in June or July

AstraZeneca CEO says the company will know by June or July whether a coronavirus vaccine it is developing with the University of Oxford will be effective or not......»»

Category: topSource: marketwatchApr 30th, 2020

Covid-19 vaccine candidate showing success in animal trials, Reuters reports

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 28th, 2020

The Daily Biotech Pulse: Amarin Reports Strong Q1 Vascepa Sales, BeiGene Aces Late-Stage Lung Cancer Study, Glaxo, Sanofi Strike COVID-19 Vaccine Partnership

The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs April 13.) Chembio Diagnostics Inc (NASDAQ: CEMI) Cytosorbents Corp (N.....»»

Category: earningsSource: benzingaApr 14th, 2020

AstraZeneca"s Drug Combo To Treat Non-Small Cell Lung Cancer Stumbles In Late-Stage Study

AstraZeneca plc (NYSE: AZN) faced a clinical setback in a study evaluating a combo drug regimen in non-small cell lung cancer, or NSCLC. read more.....»»

Category: blogSource: benzingaAug 21st, 2019

Eli Lilly, AstraZeneca Drop Two Late-Stage Alzheimer"s Drug Trials

Pharma giants AstraZeneca and Eli Lilly have scrapped two late-stage trials of an experimental Alzheimer’s drug they were co-developing, the latest blow in the long quest to find a breakthrough for the memory-robbing disorder......»»

Category: smallbizSource: wsjJun 12th, 2018

ViiV Healthcare reports positive results for late-stage HIV trials

ViiV Healthcare, which is majority-owned by GlaxoSmithKline and has Pfizer Inc. and Shionogi as shareholders, reported on Thursday positive early results from two late-stage trials testing its two-drug regimen in patient.....»»

Category: topSource: marketwatchJun 14th, 2018

Biogen Begins Improved Dosing Regimen on Tysabri in Phase III

Biogen (BIIB) commences enrollment in late-stage study to evaluate an expanded interval dosing of its MS drug.....»»

Category: personnelSource: nytJan 4th, 2019

Reports that AstraZeneca"s vaccine is less effective in older people appear to be based on botched statistics, the German government says

The European medicines regulator is expected to ma.....»»

Category: worldSource: nyt11 hr. 29 min. ago

Lilly says late-stage study showed combo therapy can reduce deaths and hospitalizations in COVID-19 patients

Shares of Eli Lilly & Co. were up 0.3% in premarket trading on Tuesday after the drugmaker said combining two of its experimental COVID-19 antibod.....»»

Category: topSource: marketwatch13 hr. 9 min. ago

Regeneron says its COVID-19 antibody cocktail can prevent infections, based on late-stage study

Shares of Regeneron Pharmaceuticals Inc. were up 1.8% in premarket trading on Tuesday after the company said its COVID-19 antibody cocktail can prevent people at high risk of a COV.....»»

Category: topSource: marketwatch13 hr. 9 min. ago

EU urges AstraZeneca to accelerate COVID vaccine deliveries, Reuters reports

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 25th, 2021

Moderna says shots effective against new COVID-19 variants, but working on new vaccine for one found in South Africa

Moderna says its vaccine is effective against new variants of the coronavirus that have emerged in Britain and S.....»»

Category: topSource: chicagotribuneJan 25th, 2021

The New York Post: Fauci suggests Johnson & Johnson COVID-19 vaccine could win emergency-use authorization in just two weeks

The first single-dose COVID-19 vaccine could get emergency approval in just two weeks, Dr. Anthony Fauci said late Friday......»»

Category: topSource: marketwatchJan 24th, 2021

The New York Post: Fauci says Johnson & Johnson COVID-19 vaccine may get approval in two weeks

The first single-dose COVID-19 vaccine could get emergency approval in just two weeks, Dr. Anthony Fauci said late Friday......»»

Category: topSource: marketwatchJan 23rd, 2021

AstraZeneca to slash EU COVID-19 vaccine deliveries by 60% in Q1, Reuters says

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 22nd, 2021

EU to see delay of AstraZeneca COVID vaccine delivery, FT reports

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 22nd, 2021